Target intelligence / Profile preview

SZT2 antisense RNA 1 (non-protein coding) (SZT2-AS1)

Target
SZT2-AS1
Molecular classification
Other (antisense non-coding RNA)
01

Overview

SZT2 antisense RNA 1 (SZT2-AS1) is a non-coding RNA transcribed antisense to the SZT2 gene locus. As an antisense RNA, it is likely to have a regulatory role in gene expression, potentially via cis- or trans-acting mechanisms such as RNA interference, modulation of transcription, or chromatin remodeling, but its exact function is not currently characterized in the literature. There is no evidence that this molecule is a protein or a therapeutic target like a receptor, enzyme, or transporter, and no disease roles or drug interactions are reported. Its annotation follows naming conventions for non-coding antisense transcripts. Notes and rationale: - There is no evidence that SZT2-AS1 encodes a protein or serves as a direct therapeutic target (such as a receptor, enzyme, transporter, or well-characterized signaling molecule). - SZT2-AS1 describes an antisense transcript at the SZT2 locus, which itself encodes a protein involved in seizure threshold, but the antisense RNA (SZT2-AS1) is non-coding and has not been described as a target in disease or drug development literature. - Thus, *is_target* is **false** and *is_incorrect* is **true** for use as a conventional drug target molecule. - Biological function entries and mechanism of action are based on general properties of antisense non-coding RNAs, not SZT2-AS1 specifically, pending further research. If you need structured information for **SZT2** protein (the sense transcript and protein-coding gene involved in epilepsy and mTOR regulation instead), that is a valid therapeutic target and can be detailed separately.

Other names
SZT2-AS1SZT2 antisense RNA 1 (non-protein coding)SZT2 antisense RNA 1
02

Biological functions

Regulation of gene expression (by potential antisense mechanisms)

Beyond the preview

Go deeper on SZT2 antisense RNA 1 (non-protein coding) (SZT2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SZT2 antisense RNA 1 (non-protein coding) (SZT2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call